Medicine access in Canada: good baseline access, but strongly tied to province and insurance
Canada receives 80 out of 100 points for medicine access. The rating is strong because the country has broad public healthcare, regulated medicine markets and additional public drug programs. The deduction matters because prescription drugs are not automatically covered in the same universal way as medically necessary hospital and physician services.
The measured value is 80 points on a 0-to-100 access scale. In practical terms, many people have good protection, but actual reimbursement depends on province, age, income, employment, private insurance and the type of medicine.
What the measured value describes
The indicator does not only ask whether pharmacies exist. The practical issue is whether a patient can obtain necessary medicines, whether public programs exist, how broad cost coverage is and whether foreigners or new residents face transition risks. Canada is strong here, but not in the top group of countries with fully uniform medicine coverage.
The reason is structural. The Canada Health Act protects eligible residents for medically necessary hospital and physician services. Other services, including prescription drugs outside hospitals, are governed by provinces and territories. That makes Canada usable, but administratively uneven.
Concrete data on medicine costs
The Canadian Institute for Health Information reported public prescription-drug spending of about $14.3 billion in 2024 (CAD 20.1 billion). Spending grew by 9.2% from the previous year. One medicine, Ozempic, accounted for about $575 million (CAD 807 million) and was the leading driver of growth in public drug spending.
- Public prescription-drug spending in 2024: about $14.3 billion (CAD 20.1 billion).
- Growth: 9.2% compared with 2023.
- Ozempic spending: about $575 million (CAD 807 million).
- High-cost biologics: about $4.2 billion (CAD 5.9 billion), roughly 29.4% of public drug spending.
- Biosimilars: about $784 million (CAD 1.1 billion), roughly 5.3% of spending.
The distribution is especially important. CIHI says nearly half of public drug spending went to about 3% of beneficiaries whose program-paid drug costs were at least about $7,130 (CAD 10,000). For people with chronic or rare diseases, the key question is therefore not just whether a program exists, but whether the exact product is listed and how cost-sharing works.
Access for foreigners and residents
For newcomers, Canada is not one uniform prescription-drug market. Anyone moving to a province needs to check when provincial health coverage starts, which drug programs apply and whether private transitional insurance is needed. Health Canada states that provinces and territories decide coverage for additional services such as prescription drugs, dental care, optometry and ambulance services.
The national pharmacare program improves access gradually, but it is not implemented identically across the whole country. Federal information currently lists agreements with British Columbia, Manitoba, Prince Edward Island and Yukon. In those participating jurisdictions, the focus is on listed contraceptives and diabetes medicines. The listed products and dispensing fees are covered; delivery charges or pharmacist prescribing fees are not automatically included.
Costs, insurance and evidence
For each medicine, the practical question is whether it is listed under the relevant public or private plan. A medicine approved in Canada is not automatically free. Deductibles, caps, age-based programs, income-based rules and employer plans can also differ sharply.
Anyone moving to Canada with regular medication needs should check three things before arrival: whether the medicine is approved and available in Canada, whether a Canadian prescription is required and whether the destination province or a private plan will pay for it. For expensive long-term therapies, the difference between covered, partly covered and not covered can amount to several thousand US dollars per year.
Regional differences and practical care
Canada has good pharmacy access in cities and suburbs, but distance and delivery logistics can matter more in rural, northern or remote areas. Provincial rules are also visible in practice: a medicine that fits well into one province's public program may require different approvals or cost-sharing in another.
For travellers, the important limit is that public coverage does not work like global drug insurance. Health Canada notes that services such as prescription drugs or ambulance services may not be covered when travelling between provinces or for visitors. Private coverage remains relevant for visitors and transition periods.
What this indicator does not measure
The indicator does not rate an individual insurance plan, pharmacy or guaranteed access to a specific medicine. It also does not say whether a new specialty drug will be reimbursed immediately. It explains the general usability of medicine access in the country.
Canada is therefore strong, but not simple. Conditions are good for routine medicines, diabetes and contraception coverage in participating jurisdictions and many public programs. For expensive specialty therapies, new products or stays without active provincial coverage, the individual cost question needs to be checked early.
Frequently Asked Questions
Are medicines automatically free in Canada?
No. Hospital and physician services are publicly covered for eligible residents, but prescription drugs outside hospitals depend on provincial programs, private insurance and the relevant drug list.
Does the national pharmacare program already apply everywhere?
No. Implementation works through agreements with provinces and territories. Health Canada currently lists British Columbia, Manitoba, Prince Edward Island and Yukon among participating jurisdictions.
Which medicines are the current focus of pharmacare?
Current federal information focuses on listed contraceptives and diabetes medicines. The listed products and dispensing fee are covered, but not necessarily every related charge.
What should newcomers check before moving?
Key checks are Canadian approval, prescription requirements, provincial coverage, private insurance, waiting periods before public coverage and possible cost-sharing for long-term therapy.
Related indicators
- Healthcare Quality in Canada
- Universal Healthcare Coverage in Canada
- Emergency Care in Canada
- Hospital Infections and Patient Safety in Canada
- Health Insurance for Foreigners in Canada
Sources
- Health Canada - what's covered under national pharmacare
- Canadian Institute for Health Information - public drug spending in Canada in 2024
- Health Canada - how publicly funded healthcare coverage works
- Banca d'Italia - ECB reference exchange rates for 16 July 2026
This article was created on July 17, 2026
